Guest guest Posted February 11, 2010 Report Share Posted February 11, 2010 Coley's Toxins (aka Mixed Bacterial Vaccine [MBV] or pyrogenic [fever-inducing] bacterial lysate/CPG 7909)—developed by B. Coley, M.D.; particularly effective w/advanced NHL (very effective w/nodular, but not very effective w/lymphosarcoma/lymphoblastic NHL) lymphoma, Hodgkins (67% 5-yr survival), w/giant-cell bone cancer (79% 5-yr survival for patients w/inoperable tumors; 87% 5-yr survival for patients w/operable tumors), Ewing's sarcoma of bone (at most 9% 5-yr survival), sarcoma of soft tissue (51% survived 10 yrs; 49% of inoperable patients survived 4 yrs; 71% of operable patients survived 4 yrs; most effective w/spindle-celled; least effective in melanotic), breast cancer (25% survived 10 yrs; 10-65% of patients w/inoperable carcinoma survived 5-8 yrs; about 75-84% of operable carcinoma patients survived 5 yrs; 5 out of 5 operable sarcoma patients survived 5 yrs; 2 out of 7 inoperable sarcoma patients survived 8 yrs), inoperable ovarian cancer (67% 5-yr survival; 10-yr median survival if cancer was confined to ovary), colorectal (about 60% 5-yr survival for inoperable), melanoma (71% 5-yr survival for operable; 64% 5-yr survival for inoperable; effective even w/patients who've had chemo), testicular (87% long-term survival for patients w/operable tumors; 33% 5-yr survival for patients w/inoperable tumors), neuroblastoma (about 33% 5-yr survival). Apparently a little effective w/stage 3 lung carcinoma [NSCLC]. Another study reported 45% five year survival with inoperable tumors and 50% with operable tumors. I believe it's also had some success w/liver & uterine cancer. Increased life expectancy of kidney cancer patients to 6.5 years but didn't decrease the likelihood of [eventual] death [didn't produce permanent recoveries] in " soft-tissue " [sarcoma], kidney, ovarian, breast cancer patients (Moss, 1992, p. 408; Diamond et al., 1997, pp. 880-882; et al., 1999; www.mdanderson.org/education-and-research/resources-for-professionals/clinical-t\ ools-and-resources/cimer/therapies/nonplant-biologic-organic-pharmacologic-thera\ pies/coley-toxins.html) “results...over a 1000 people were treated with [Coley’s toxins]…advanced terminal breast cancer…complete remissions in 50% of the cases†Ralph Moss on Chemotherapy, Laetrile, Coley's Toxins, Burzynski, & Cancer Politics ( Lee radio show, 1994) www.whale.to/c/moss.html Coley's toxins produce a therapeutic fever and powerful immune response that is highly effective in killing cancer cells. Mistletoe’s synergistic w/Coley’s. Coley’s is contraindicated for brain mets because it causes inflammation (Moss, 2008). For more info, see www.cancerguide.org/coley.html www.second-opinions.co.uk/coleys_toxin2.html www.waisbrenclinic.com/cancerpaper.pdf www.cancerdecisions.com/091802.html & www.cancerdecisions.com/112902.html www.cancerdecisions.com/mrstore/index.php?main_page=product_info & cPath=84 & produc\ ts_id=627 (100-pg report) www.apricotsfromgod.org/ralphmoss.htm (little info) www.mdanderson.org/education-and-research/resources-for-professionals/clinical-t\ ools-and-resources/cimer/therapies/nonplant-biologic-organic-pharmacologic-thera\ pies/coley-toxins.html , Ann, Tina , C. , & Lemuel A. Moye (May, 1999). Coley Toxins Immunotherapy: A Retrospective Review. Alternative Therapies in Health and Medicine. Cancer Research Institute (CRI) www.cancerresearch.org “Cancer Research Institute [www.cancerresearch.org] and the Ludwig Institute for Cancer Research have established a partnership called the Cancer Vaccine Collaborative [CVC]. One of the projects of the CVC is to evaluate a modern day version of Coley’s Toxins. The first step in this project has been completed by the production of a Mixed Bacterial Vaccine (MBV)....We expect a small Phase I trial of MBV to initiate by the end of 2006 in furt, Germany. The purpose of this first trial will be to evaluate the safety of MBV and to measure the immunological effects of various doses " 2/06†Coley's toxins treatment is available at the San Diego Clinic (www.sdiegoclinic.com), CHIPSA.com, www.hufeland.com (“fever therapyâ€) and Issels.com at Oasis in Tijuana. Dr. Kudelka at Pfizer, 914-301-5166, “in charge of…lung… and possibly breast cancer…trials on the horizon with chemo and Coley’s Toxins (now called CPG 7909)….Pfizer now owns the `patent’†Bethel, MD at www.aacancer.com is doing Coley's clinical trial as of 2007 Fast for a few days prior to taking Coley’s. “my many years of research on Dr B. Coley " A. Hoption Cann, PhD, University of British Columbia, 4/09 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.